CV Sciences, Inc.
CVSI
$0.03
$0.00196.76%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 2.18% | -5.48% | -0.30% | -3.52% | -1.76% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 2.18% | -5.48% | -0.30% | -3.52% | -1.76% |
| Cost of Revenue | 7.19% | -7.08% | -6.85% | -9.17% | -10.75% |
| Gross Profit | -3.73% | -3.53% | 8.27% | 3.98% | 11.52% |
| SG&A Expenses | -12.18% | -10.27% | -22.09% | 13.03% | -3.03% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -3.42% | -8.84% | -14.87% | 386.37% | -6.74% |
| Operating Income | 36.83% | 40.27% | 89.30% | -110.76% | 28.40% |
| Income Before Tax | 15.72% | -2.01% | 54.55% | -110.90% | 73.25% |
| Income Tax Expenses | -55.56% | -- | -- | -- | 81.63% |
| Earnings from Continuing Operations | 16.46% | -2.01% | 54.66% | -111.01% | 73.12% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 16.46% | -2.01% | 54.66% | -111.01% | 73.12% |
| EBIT | 36.83% | 40.27% | 89.30% | -110.76% | 28.40% |
| EBITDA | 50.09% | 52.51% | 99.02% | -109.57% | 29.56% |
| EPS Basic | 30.36% | 13.79% | 59.52% | -110.40% | 73.83% |
| Normalized Basic EPS | 32.00% | 27.78% | 92.50% | -110.26% | 46.81% |
| EPS Diluted | 31.58% | 13.79% | 59.52% | -110.40% | 73.36% |
| Normalized Diluted EPS | 32.00% | 27.78% | 92.50% | -110.26% | 46.81% |
| Average Basic Shares Outstanding | 17.80% | 17.89% | 12.99% | 7.21% | 3.50% |
| Average Diluted Shares Outstanding | 17.80% | 17.89% | 12.99% | 7.21% | 3.50% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |